Sarasota, FL 4/1/2008 9:48:00 PM
CDEX (OTCBB: CEXI) Meth Scanner Successful in Detection Tests
Pennycents Magazine reports on CDEX Inc.
Pennycents Magazine, the market’s most valuable research tool covering micro-cap, penny stocks and otcbb equities, issued the following daily column by Lester Young.
Crystal Meth is a dangerous illegal drug. Not only can direct use of the substance have potentially deadly consequences, the long-term health impact of passive (or second-hand) exposure to methamphetamine is not fully understood. The risks of continued exposure for an unsuspecting public in areas where the drug was previously used – such as a home, apartment or automobile – could be significant and perhaps even life-threatening. The CDEX ID2 "Meth Scanner" has been designed to be a quick and low-cost tool to identify such hazardous locations before they're entered in order to minimize the overall public risk.
CDEX, Inc. (OTCBB: CEXI.OB), whose headquarters and research/development facilities are located in Tucson, Arizona, uses its patented and patent-pending technologies to develop products that can identify potentially dangerous substances (for example, explosives or illegal drugs) or validate substances for purposes of anti-counterfeiting, quality assurance and brand protection (e.g., validating compound medications and detecting substandard or counterfeit wares). During recent tests conducted in four different law enforcement jurisdictions, the ID2 Meth Scanner correctly identified 32 different samples of methamphetamine in clear containers with no errors, including Strawberry, Rose, Peanut Butter, Mexican and Crystal Meth forms of the substance. Additionally, in a separate sensitivity test, the ID2 detected and identified the drug at 1.0 micrograms per 100 cubic centimeters, a level 33% below the proposed California health-based methamphetamine remediation standard of 1.5 micrograms per 100 cubic centimeters.
The handheld, battery-operated ID2 Meth Scanner provides instantaneous results without disturbing the surfaces that are under examination. The first 200 scanners are currently in production, with delivery to a waiting client base expected during the second quarter of this year. Numerous potential users from around the world have expressed interest in the product, including police departments, hospitals, school districts and property inspectors. The company's ValiMed Medication Validation System currently in use in major U.S. hospitals also employs the Meth Scanner technology.
The writer does not own shares in the above stocks.
Subscribe to Pennycents Magazine ($9.95 yr)About Pennycents Magazine
Pennycents Magazine, along with the Pennycents.com web site, features information on up-and-coming micro-cap, and penny stock companies listed on the OTCBB and Pink Sheets, as well as commentary on the factors that influence the market. As a totally unbiased penny stock information platform, Pennycents does not accept payment from the companies mentioned in its articles or columns. Neither Pennycents, nor its staff or writers, are allowed to invest in companies featured in the magazine. You can have Pennycents mailed to your door or learn more by visiting its website at http://www.pennycents.com.
PC Capital Holdings, LLC (Pennycents) believes the information contained herein to be accurate and reliable as of the issue publication date. The information contained herein is not guaranteed or warranted by Pennycents to be accurate, and should not be considered to be all-inclusive. The companies that are written about in Pennycents have not approved the statements made in this disclaimer. Information contained herein may contain forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or a solicitation of an offer to buy or sell securities. Pennycents is a magazine and not a licensed broker, broker/dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a licensed broker before purchasing or selling any securities viewed on http://www.pennycents.com or mentioned herein.
